Close Menu

NEW YORK – European investment firm ArchiMed announced on Tuesday that it has acquired Austrian in vitro diagnostics company EuroLyser for an undisclosed amount.

ArchiMed, which is based in Lyon, France, also acquired EuroLab, the main distributor for EuroLyser. In a statement, ArchiMed said the transaction was "triggered by the retirement of one of EuroLyser's cofounders."

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.